Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasms × Tissue Banks × Clear all

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thoracic Diseases 1 Skin Neoplasms 1 Sarcoma 1 Prolactinoma 1 Pituitary ACTH Hypersecretion 1 Paraproteinemias 1 Pancreatic Ductal Adenocarcinoma 1 Nervous System Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Monoclonal Gammopathy of Undetermined Significance 1 Lung Neoplasms 1 Leiomyosarcoma 1 Immunoglobulin Light-chain Amyloidosis 1 Gigantism 1 Endometrial Neoplasms 1 Congenital Abnormalities 1 Combined Pituitary Hormone Deficiency 1 Colorectal Neoplasms 1 Clear-cell metastatic renal cell carcinoma 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Carcinosarcoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 31 Blood Specimen Collection 29 Bevacizumab 18 Standard of Care 16 Radiotherapy 15 Carboplatin 14 Surveys and Questionnaires 13 Paclitaxel 13 Nivolumab 13 Exercise 13 Cisplatin 11 atezolizumab 10 Drug Therapy 10 Docetaxel 10 Dexamethasone 10 Cyclophosphamide 9 Pemetrexed 8 Fluorouracil 8 olaparib 7 Trastuzumab 7 Temozolomide 7 Leucovorin 7 Irinotecan 7 Interviews as Topic 7 Cetuximab 7 pertuzumab 6 Radiosurgery 6 Panitumumab 6 Oxaliplatin 6 Observation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05324553 2025-05-02

Patient Derived Preclinical Models

Mayo Clinic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡